Want to join the conversation?
$LH stated that it added complementary capabilities through targeted tuck-in acquisitions like Safe Foods, the company's premier food safety lab. Through the last six months, three oncology companion diagnostics received FDA approval through the support of $LH by partnering in clinical trials and helping in regulatory submission.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.